|
PMT1-MEDIATED O-GLYCOSYLATION IS REQUIRED FOR CANDIDA ALBICANS BIOFILM
FORMATION (click for details) |
|
|
|
DETECTION OF SYSTEMIC ASPERGILLUS INFECTIONS BY IN SITU HYBRIDIZATION
TECHNIQUE WITH A SPECIES-SPECIFIC DNA PROBE (click for details) |
|
|
|
ICU-ACQUIRED CANDIDEMIA AND CANDIDURIA : EPIDEMIOLOGY AND MANAGEMENT.
RESULTS OF A PROSPECTIVE MULTICENTER STUDY (click for details) |
|
|
|
TWO DIFFERENT FACES OF ASPERGILLOSIS (click for details) |
|
|
|
NOVEL ERG11 POINT MUTATIONS FROM CANDIDA ALBICANS BLOODSTREAM
ISOLATES WITH REDUCED SUSCEPTIBILITIES TO AZOLE ANTIFUNGALS. (click for details) |
|
|
|
DNA SEQUENCE ANALYSIS AND PHENOTYPIC METHODS ROUTINELY IDENTIFY YEASTS
FROM PATIENT SPECIMENS (click for details) |
|
|
|
HOW DOES DNA SEQUENCING FIT INTO A CLINICAL MYCOLOGY LABORATORY FOR
THE IDENTIFICATION OF YEAST AND FILAMENTOUS MOLDS? (click for details) |
|
|
|
LACK OF INFUSION-RELATED ADVERSE EVENTS WITH ANIDULAFUNGIN (ANID) (click for details) |
|
|
|
CORRELATIONS BETWEEN THE PROPOSED PROCEDURE FOR ANTIFUNGAL
SUSCEPTIBILITY TESTING (AFST) OF THE EUROPEAN COMMITTEE ON ANTIBIOTIC
SUSCEPTIBILITY TESTING (EUCAST), THE MICROMETHOD OF THE NCCLS, AND TWO
COMMERCIAL TECHNIQUES, ETEST AND SENSITITRE YEASTONE (click for details) |
|
|
|
LONG-TERM FOLLOW UP OF ONYCHOMYCOSIS TREATMENT (click for details) |
|
|
